Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2008
12/17/2008EP2001866A2 Organic compounds
12/17/2008EP2001855A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
12/17/2008EP2001848A1 Piperidines and related compounds for the treatment of dementia
12/17/2008EP2001846A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
12/17/2008EP2001843A2 Soluble adenylate cyclase inhibitors
12/17/2008EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
12/17/2008EP2001474A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1773763B1 Lysine based compounds
12/17/2008EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
12/17/2008EP1282609B1 Piperazinedione compounds
12/17/2008EP1222305B1 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams
12/17/2008CN101326179A New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
12/17/2008CN101326177A Dihydroisoindolones as allosteric modulators of glucokinase
12/17/2008CN101326174A Compound having hydrocoumarin skeleton, liquid crystal composition and liquid crystal display element
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN101323612A Preparation of bactericide propiconazole
12/17/2008CN100443482C Benzofuran derivatives and their use in the treatment of microbial infections
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease
12/16/2008US7465808 3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-2-m-tolyl-propionic acid and Na salt; 3-[5-Benzo[1,3]dioxol-5-yl-1-(2,5-dichloro-phenyl)-1H-pyrazol-3-yl]-2-(3-chloro-phenyl)-acrylic acid; 5-{(S)-2-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-pyrazol-3-yl]-1-m-tolyl-ethyl}-1H-tetrazole
12/16/2008US7465799 Methods and compositions for selectin inhibition
12/16/2008US7465751 respiratory, urinary and gastrointestinal systems disorders; 2-cyclopentyl-2-hydroxy-N-[(3S)-1-benzyl-pyrrolidin-3-yl]-2-phenyl acetamide; side effects reduction; compounds exhibit significant potency
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465744 Triazole compounds and the therapeutic use thereof
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
12/16/2008US7465724 e.g. 1,4-bis-{3-[7-methoxy-8-oxy-(11aS)-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one]propyloxy}anthracene-9,10-dione; antitumor agent; lung, cervix, breast, colon, prostate and ovary cancer cell lines
12/16/2008US7465720 Proteasome inhibiting β-lactam compounds
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/11/2008WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/11/2008WO2008149965A1 Pyridone compound
12/11/2008WO2008149191A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008WO2008149160A1 Amorphous olmesartan medoxomil
12/11/2008WO2008149155A1 Crystalline form b of olmesartan medoxomil
12/11/2008WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
12/11/2008WO2008148889A1 Fungicide heterocyclyl-pyrimidinyl-amino derivatives
12/11/2008WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor
12/11/2008WO2008148302A1 Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
12/11/2008WO2008109181A3 Metalloprotease inhibitors containing a heterocyclic moiety
12/11/2008WO2008103693A3 Chemical linkers with single amino acids and conjugates thereof
12/11/2008WO2008088969A3 Synthesis of selected stereoisomers of certain substituted alcohols
12/11/2008WO2007089462A3 Piperidine and piperazine derivatives
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306117 Ep4 receptor antagonists
12/11/2008US20080306116 Aryloxazole, aryloxadiazole and benzimidazole derivatives
12/11/2008US20080306111 Tricyclic delta- opioid modulators
12/11/2008US20080306101 Insecticidal Spironindane Derivatives
12/11/2008US20080306096 Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306064 Benzimidazole Derivatives
12/11/2008US20080306062 Modulators of atp-binding cassette transporters
12/11/2008US20080306061 Aminophenylsulfonamide Derivatives as Hiv Protease Inhibitor
12/11/2008CA2693552A1 Pyridone compound
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008CA2690101A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions
12/11/2008CA2689337A1 Crystalline form b of olmesartan medoxomil
12/11/2008CA2685588A1 Fungicide heterocyclyl-pyrimidinyl-amino derivatives
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP1999117A2 Renin inhibitors
12/10/2008EP1638958A4 Zwitterionic non-linear optophores and devices incorporating same
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008CN101321768A 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
12/10/2008CN101321766A Substituted benzofused derivatives and their use as vanilloid receptor ligands
12/10/2008CN101321749A Novel vinylogous acids derivatives
12/10/2008CN101321747A Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase
12/10/2008CN101321745A Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
12/10/2008CN101321736A Compounds which have activity at m1 receptor and their uses in medicine
12/10/2008CN101321731A Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
12/10/2008CN101321728A Diaminoarylene compound having carbazolyl group and use thereof
12/10/2008CN101318938A Method for synthesizing quinoxaline derivant
12/10/2008CN100441571C Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
12/09/2008US7462630 Diarylalkene derivatives and novel diarylalkane derivatives
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462620 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
12/09/2008US7462612 Pyridine inhibitors of ERK2 and uses thereof
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2352054C New amidino derivatives and their use as thrombin inhibitors
12/09/2008CA2326045C Pde iv inhibiting pyridine derivatives
12/09/2008CA2294059C New amidino derivatives and their use as thrombin inhibitors
12/04/2008WO2008147786A1 ((bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
12/04/2008WO2008147697A1 Benzimidazolone chymase inhibitors
12/04/2008WO2008147314A1 Spirocyclopropyl piperidine derivatives
12/04/2008WO2008146871A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146064A1 New benzofuran derivatives as selective 5ht7 receptor inhibitors and process for their preparation
12/04/2008WO2008146063A1 New benzofuran derivatives as selective 5ht6 receptor inhibitors and process for their preparation
12/04/2008WO2008145605A1 Improved synthesis of (2s-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester)
12/04/2008WO2008145398A1 4-arylpyrrole substituted 2-indoline derivatives active as protein kinase inhibitors
12/04/2008WO2008119771A3 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
12/04/2008WO2008076336A3 Imidazoles as aldosterone synthase inhibitors
12/04/2008US20080300407 Pyridinoylpiperidines as 5-HT1F agonists
12/04/2008US20080300398 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents; HIV
12/04/2008US20080300254 Tylophorine Analogs as Antitumor Agents
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 694